Announcement • Jul 07
Rocket Doctor Ai Inc. Announces CFO Changes Rocket Doctor AI Inc. had appointed Mr. Andrew Lau, CPA, CA as Chief Financial Officer, effective July 6, 2026. Mr. Lau brought over 18 years of capital markets, corporate finance, and public company experience to Rocket Doctor AI. Throughout his career, he had held executive finance leadership roles with high-growth technology and life sciences companies, where he had led corporate finance, treasury, financial reporting, corporate development, and public company initiatives. Mr. Lau began his career with Deloitte LLP, where he earned his Chartered Professional Accountant designation, before joining RBC Capital Markets as an investment banker specializing in M&A and equity financing transactions. Over the course of his career, he had advised on and executed more than $700 million in M&A and capital markets transactions and had played a key role in helping emerging growth companies scale, strengthen their financial operations, and access the public markets. Mr. Lau replaced Mr. Chris Cherry, who stepped down as Interim CFO to return to his role as Chair of the Audit Committee while continuing his service as a director. AIDR
Live News • Jul 01
Rocket Doctor AI Secures First US Value-Based Care Deal Expanding Access for 5 Million Members Rocket Doctor AI has entered its first value-based primary care provider agreement in the US with a California independent physician association, expanding its in-network coverage to more than 5 million patients across multiple payer types under a recurring per-member-per-month model.
The deal gives Rocket Doctor AI a foothold in California and shifts a portion of its business toward value-based care, with an emphasis on continuity of care, preventive health and long-term patient outcomes, which could influence how revenue is earned and recognized.
Rocket Doctor AI shares last traded at CA$0.60, with the stock down 26.8% year to date.
This move introduces a recurring revenue framework tied to patient panels rather than one-off visits. This structure can change both growth potential and execution risk, particularly around care quality, cost control and relationship management with payers and physicians. Announcement • Jun 17
Treatment.Com Inc Receives Year 2 Funding from National Institute on Minority Health and Health Disparities Rocket Doctor AI Inc. announced that Treatment.com Inc., in collaboration with Rush River Research, had received confirmation of second-year funding from the National Institute on Minority Health and Health Disparities, part of the National Institutes of Health. The funding granted follows the successful completion of the program’s first-year milestones and extends support for the development of an AI-powered family medical history tool designed to make preventive care more accurate, accessible, and culturally responsive. The second-year award provides Treatment with in excess of USD 250,000 in additional support, with the program agreement now extended through May 31, 2027. This extension provides Treatment with over USD 500,000 to enhance its Global Library of Medicine and AI-powered clinical tools. The two-year project is supported by a highly competitive Small Business Innovation Research grant with a total award value of approximately USD 2 million. As part of the Year 2 extension, Treatment will receive more than USD 250,000 in additional funding, bringing its total program support to more than USD 500,000. The project agreement now extends through May 31, 2027. 
